Mycophenolic acid is a medicine used to prevent certain types of infections. It works by stopping the growth of specific types of immune cells (like T-cells and B-cells) that fight infections. It's often used after organ transplants to prevent rejection.
Every report comes from a Lived member, sent anonymously.
Have you tried Mycophenolic Acid for Lupus Nephritis?
Mycophenolic acid is a prescription immunosuppressant, a medicine that dampens the immune system, used to help prevent the body from rejecting a transplanted kidney. Rejection happens when the immune system recognizes the new organ as foreign and attacks it. In the US, mycophenolic acid is sold as delayed-release tablets under the brand name Myfortic and as generics, whose labels may also say mycophenolate sodium. It is approved for adults receiving a kidney transplant and for children 5 and older whose kidney transplant is at least 6 months old. It is never the only anti-rejection medicine: the approved regimen combines it with cyclosporine (another anti-rejection drug) and a corticosteroid (steroid) medicine. A closely related medicine, mycophenolate mofetil (CellCept), is converted by the body into mycophenolic acid. CellCept is approved more broadly, for kidney, heart and liver transplants in adults and children from 3 months of age. The two products are absorbed differently and are dosed differently, so one should not be swapped for the other except under the prescriber's direction. Some specialists also use mycophenolic acid off label for lupus nephritis, the kidney inflammation caused by lupus, for example when mycophenolate mofetil upsets the stomach.
Organ rejection is driven by immune cells called lymphocytes (T cells and B cells). When they detect the donor kidney, they multiply rapidly, and to do that they need a steady supply of purines, the chemical building blocks of new DNA. Most cells in the body can recycle purines, but lymphocytes depend heavily on making new ones through a pathway that relies on an enzyme called IMPDH (inosine monophosphate dehydrogenase). Mycophenolic acid blocks that enzyme, so lymphocytes cannot multiply as readily and B cells make fewer antibodies. The immune attack on the transplanted kidney is weaker as a result. The same effect also lowers the body's defenses against infections and some cancers, which is why the main risks of this medicine follow directly from how it works. The tablets have a coating that keeps them intact in the stomach so the medicine dissolves in the intestine, which is why they are called delayed release.
Mycophenolic acid comes as 180 mg and 360 mg delayed-release tablets taken by mouth twice a day. The usual adult dose is 720 mg twice daily; children's doses are based on body size. Take it on an empty stomach, 1 hour before or 2 hours after eating, and swallow the tablets whole. Crushing, chewing or cutting a tablet damages the protective coating. If a dose is missed, take it when you remember, unless the next dose is nearly due; in that case skip the missed one, and never take two doses together. If you take more than prescribed, call the doctor right away. Do not stop taking it or change the dose on your own, because lowering immunosuppression can put the transplanted kidney at risk. Changes are made by the transplant team.
Digestive problems are the most common side effects: constipation, nausea, diarrhea, vomiting and indigestion each affected roughly one in five people or more in the main kidney transplant trial. Low red or white blood cell counts, urinary tract infections, trouble sleeping and leg swelling were also common. Transplant recipients take several medicines at once, so not every effect comes from this one, and many can be managed with the transplant team's help. Because it weakens the immune system, infection is the most important everyday risk. Infections range from ordinary urinary and respiratory infections to viruses the immune system normally keeps in check, such as cytomegalovirus (CMV, which can infect the blood and organs), shingles, and BK virus, which can damage the transplanted kidney. Call the transplant team right away for a temperature of 100.5°F or higher, cold or flu symptoms, pain when urinating, white patches in the mouth, a cut or incision that is red, warm or oozing pus, or unexpected bruising or bleeding. Rarely, a serious brain infection called PML (progressive multifocal leukoencephalopathy) occurs; new weakness on one side of the body, confusion, loss of interest in usual things or loss of muscle control should be reported right away. Less often, mycophenolic acid causes bleeding, ulcers or a tear in the stomach or intestine; call the team promptly for signs of bleeding in the digestive tract or sudden or persistent belly pain. An uncommon inflammatory reaction, with fever, joint stiffness, joint pain or muscle pain, can appear weeks to months after starting or increasing the dose and also warrants a prompt call. Severe allergic reactions are rare and usually appear within hours to a day of starting. Stop the medicine and call 911 for swelling of the face, lips, tongue or throat, trouble breathing or swallowing, fainting, or chest pain.
Mycophenolic acid can seriously harm a pregnancy. Use during pregnancy raises the risk of miscarriage in the first trimester and of birth defects affecting the ears, face (including cleft lip and palate), heart, limbs and other organs. In pregnancy registries for the closely related mycophenolate mofetil, nearly half of exposed pregnancies ended in first-trimester loss, and about a quarter of babies born alive had malformations. Anyone who could become pregnant needs a pregnancy test right before starting and another 8 to 10 days later, repeat tests at follow-up visits, and acceptable birth control throughout treatment and for 6 weeks after stopping. The medicine lowers hormone levels from birth control pills, so anyone using the pill must add a second method such as condoms. If you are planning a pregnancy, talk with the transplant team first about switching to an anti-rejection medicine with less risk. If you become pregnant, do not stop the medicine on your own; call the doctor right away. Men taking it should use effective contraception with a partner who could become pregnant, and should not donate sperm, during treatment and for 90 days afterward. Whether to breastfeed is a decision to make with the doctor, because data are limited. Long-term immunosuppression raises the risk of lymphoma (a cancer of the immune system) and other cancers, especially skin cancer. The risk reflects how strong and how long the immunosuppression is rather than this drug alone. Limiting time in the sun, avoiding tanning beds, wearing protective clothing and using broad-spectrum sunscreen of SPF 30 or higher all help, as does reporting a new skin growth or a mole that changes size or color. Several medicines change how much mycophenolic acid reaches the blood. Antacids containing magnesium or aluminum should not be taken at the same time. Cholestyramine (a cholesterol-lowering powder) and sevelamer (a phosphate binder used in kidney disease) can lower its levels and are not recommended with it. Azathioprine, an older immunosuppressant that acts on the same purine pathway, should not be combined with it. Switching from cyclosporine to another anti-rejection medicine, or the reverse, can shift mycophenolic acid levels. Antivirals used against herpes viruses and CMV, such as acyclovir and valganciclovir, can raise levels of both medicines, so blood counts are watched. Tell the transplant team and pharmacist about every prescription, over-the-counter medicine and supplement. Live vaccines should be avoided, and other vaccines may work less well, so check with the transplant team before any vaccination. Do not donate blood during treatment and for 6 weeks after stopping. Mycophenolic acid should not be taken by anyone who has had an allergic reaction to it or to mycophenolate mofetil, or by people with a rare inherited enzyme deficiency called HGPRT deficiency (as in Lesch-Nyhan syndrome). People with ulcers or other active digestive disease need extra caution.
Mycophenolic acid works in the background: there is no symptom that tells you it is working. Its success shows up as a stable transplanted kidney, followed through regular blood tests at transplant clinic visits. Blood counts are checked closely at first: weekly during the first month, twice a month in the second and third months, then monthly through the first year. If white or red blood cell counts drop too low, the team may pause the medicine or lower the dose. Dose adjustments are common. In the main trial, more than half of patients had their dose reduced at least once in the first year, most often because of side effects, so a change is a normal part of treatment rather than a sign that something has gone wrong. Adults 65 and older may have more side effects because of a weaker immune system. Day to day, living with this medicine means taking it at consistent times on an empty stomach, protecting your skin from the sun, checking with the team before vaccines or new medicines, and calling quickly when signs of infection appear.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Mycophenolic Acid, what you've noticed, or ask the community a question.